COVID-19: Systematic Review
-
Clinical outcomes of COVID-19 amongst HIV patients: a systematic literature review
-
Thomas Massarvva
-
Epidemiol Health. 2021;43:e2021036. Published online May 17, 2021
-
DOI: https://doi.org/10.4178/epih.e2021036
-
-
10,312
View
-
409
Download
-
1
Citations
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
The global pandemic coronavirus disease 2019 (COVID-19) emerged in the city of Wuhan, China around December 2019. Since then, the virus has caused severe morbidity and mortality worldwide and has put pressure on the global medical system. Still, there are limited data regarding the clinical impact of COVID-19 on people living with human immunodeficiency virus (HIV). The primary aim of this study was, therefore, to systematically review up-to-date studies reporting the clinical outcomes of COVID-19 amongst HIV patients.
METHODS
A thorough literature search was carried out using MEDLINE, Embase, Scopus, and the Cochrane Library Databases in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
RESULTS
A total of 22 studies were identified. Amongst 730 HIV/COVID-19-coinfected patients, 79.4% were males, the median age was 51.5 years, and the number of reported patients receiving antiretroviral drugs was 708 (97.2%). Most coinfected patients had mild to moderate symptoms, including cough (37.7%), fever (37.5%), and dyspnoea (24.7%). Among pre-existing comorbidities, hypertension (26.3%) was the most prevalent in HIV/COVID-19 coinfected patients, and 87% of coinfected patients recovered.
CONCLUSIONS
Based on the existing data in this systematic literature review, HIV patients with pre-existing comorbidities, obesity, and older age should be considered as a high-risk group for COVID-19. Furthermore, coinfected patients appear to have marginally comparable clinical outcomes with the general population. The study’s findings highlight the need for further investigation to elucidate the impact of COVID-19 infection on HIV patients.
-
Summary
Key Message
In this systematic literature review, various aspects of COVID-19 outcomes amongst HIV patients are identified and quantified, including the proportion of different symptoms, severity, pre-existing comorbidities, recovery, death, and the most commonly prescribed antiretroviral drugs in HIV patients with COVID-19 coinfection.
-
Citations
Citations to this article as recorded by

- Double Trouble Co-Infections: Understanding the Correlation Between COVID-19 and HIV Viruses
Sassi Ashraf Ali Abbasi, Tarika Noor, Maneeth Mylavarapu, Monika Sahotra, Hunmble A Bashir, Rakshita Ramesh Bhat, Urmi Jindal, Uzma Amin, Anushree V, Humza F Siddiqui
Cureus.2023;[Epub] CrossRef
Original Article
-
Major enteropathogens in humans, domestic animals, and environmental soil samples from the same locality: prevalence and transmission considerations in coastal Odisha, India
-
Arpit Kumar Shrivastava
, Nirmal Kumar Mohakud
, Swagatika Panda
, Saumya Darshana Patra
, Subrat Kumar
, Priyadarshi Soumyaranjan Sahu
-
Epidemiol Health. 2020;42:e2020034. Published online May 26, 2020
-
DOI: https://doi.org/10.4178/epih.e2020034
-
-
14,197
View
-
156
Download
-
1
Citations
-
Abstract
PDF
Supplementary Material
-
Abstract
Objectives
Regions with limited sanitation facilities have higher rates of infections with various enteric pathogens. It is therefore important to identify different hosts and their relative contribution to pathogen shedding into the environment, and to assess the subsequent health risks to humans.
Methods
In this study, human faecal (n=310), animal faecal (n=150), and environmental (soil) samples (n=40) were collected from the same locality and screened for selected enteric pathogens by immunochromatography and/or polymerase chain reaction.
Results
At least 1 microbial agent was detected in 49.0%, 44.7%, and 40.0% of the samples from human, animals, and soil, respectively. Among humans, rotavirus was predominantly detected (17.4%) followed by enteropathogenic <i>Escherichia coli</i> (EPEC) (15.4%), Shigella (13.8), and Shiga toxin-producing <i>E. coli</i> (STEC) (9.7%). Among animals, STEC was detected most frequently (28.0%), and EPEC was the major enteric pathogen detected in soil (30.0%). The detection rate of rotavirus was higher among younger children (≤2 years) than among older children. Single infections were more commonly detected than multiple infections in humans (p<0.01), unlike the observations in animal and soil samples. For diarrhoeagenic <i>E. coli</i> and <i>Shigella</i>, most of the human and animal isolates showed close relatedness, suggesting possible cross-infection between humans and domesticated animals in the area studied.
Conclusions
The present study provides an improved understanding of the distribution of major enteric pathogens coexisting in humans and animals in the region, thereby suggesting a high potential for possible transmission among livestock and communities residing in the studied locality.
-
Summary
-
Citations
Citations to this article as recorded by

- In vitro antioxidant and antidiarrheal activities of aqueous and n-hexane extracts of Cucurbita maxima seed in castor oil-induced diarrheal rats
Habibu Tijjani, Adamu Matinja, Marwanatu Yahya, Emmanuel Aondofa, Akibu Sani
Natural Resources for Human Health.2022; 2(2): 246. CrossRef